Aa
A
A
Close
1569985 tn?1328251082
FDA Alert for Cardiac drug
New FDA Medwatch Alert
Sent to subscribers of: olmesartan systemic, olmesartan
Drug Safety Communication: Olmesartan Medoxomil - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
July 3, 2013
Audience: Health Professional, Cardiology, Patient.
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy. Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. FDA has approved changes to the labels of these drugs to include this concern. Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan. Read more.
More FDA Medwatch Alerts...
Cancel
0 Answers
Page 1 of 1
Your Answer
Avatar universal
Answer
Do you know how to answer? Tap here to leave your answer...
Answer
Answer
Post Answer
A
A
Top Arrhythmias Answerers
Recent Activity
Avatar universal
Blank
AlanW2060 added the Weight Tracker
May 25
363281 tn?1353103243
Blank
SassyLassie commented on I had no idea there w...
May 22
19599991 tn?1494286813
Blank
GlikeGiraffe is awake Comment
May 08
Heart Rhythm Community Resources